Abstract
Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.
Publication types
-
Guideline
-
Practice Guideline
MeSH terms
-
Administration, Oral
-
Amiodarone / administration & dosage
-
Amiodarone / adverse effects
-
Amiodarone / therapeutic use*
-
Anti-Arrhythmia Agents / administration & dosage
-
Anti-Arrhythmia Agents / adverse effects
-
Anti-Arrhythmia Agents / therapeutic use*
-
Arrhythmias, Cardiac / drug therapy
-
Drug Interactions
-
Humans
-
Infusions, Intravenous
-
Randomized Controlled Trials as Topic
Substances
-
Anti-Arrhythmia Agents
-
Amiodarone